| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
215,726 |
180,214 |
$44.09M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
148,440 |
103,080 |
$171K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
58,784 |
40,351 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,387 |
17,215 |
$28K |
| 90670 |
|
2,730 |
2,001 |
$15K |
| 0012A |
|
163 |
163 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
504 |
366 |
$10K |
| J3490 |
Unclassified drugs |
90 |
90 |
$9K |
| 0011A |
|
157 |
157 |
$8K |
| 90710 |
|
711 |
472 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,088 |
3,442 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,583 |
3,210 |
$6K |
| 92552 |
|
13,281 |
9,326 |
$5K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,591 |
3,795 |
$5K |
| 99000 |
|
54,778 |
43,932 |
$5K |
| 90734 |
|
1,007 |
790 |
$5K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
145 |
133 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,617 |
1,922 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
41,724 |
34,762 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,197 |
2,322 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
2,882 |
2,072 |
$4K |
| 90686 |
|
8,621 |
6,428 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
840 |
712 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,697 |
2,743 |
$2K |
| 90647 |
|
2,523 |
1,891 |
$2K |
| 90723 |
|
2,048 |
1,501 |
$2K |
| 99215 |
Prolong outpt/office vis |
1,079 |
864 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,009 |
1,248 |
$1K |
| 81025 |
|
5,294 |
4,371 |
$1K |
| 90651 |
|
1,957 |
1,391 |
$1K |
| 96150 |
|
885 |
704 |
$1K |
| 90649 |
|
64 |
55 |
$978.48 |
| 59425 |
|
8,070 |
5,275 |
$922.34 |
| 81002 |
|
18,703 |
11,494 |
$849.91 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,801 |
1,715 |
$847.92 |
| 90700 |
|
1,233 |
851 |
$838.88 |
| 3045F |
|
521 |
510 |
$806.25 |
| 0002A |
|
12 |
12 |
$804.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
259 |
204 |
$662.60 |
| 95251 |
|
176 |
167 |
$584.43 |
| 90715 |
|
1,299 |
964 |
$548.24 |
| 90633 |
|
1,274 |
902 |
$485.53 |
| 85018 |
|
19,881 |
14,934 |
$455.10 |
| 90696 |
|
388 |
265 |
$444.88 |
| 82948 |
|
6,956 |
5,438 |
$383.24 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
1,234 |
1,174 |
$366.30 |
| 3044F |
|
565 |
554 |
$315.00 |
| 99381 |
|
337 |
280 |
$314.16 |
| 96127 |
|
5,135 |
3,472 |
$304.64 |
| 90746 |
|
66 |
51 |
$274.84 |
| 1160F |
|
5,603 |
5,252 |
$251.69 |
| 83037 |
|
8,262 |
6,091 |
$176.51 |
| 82947 |
|
6,614 |
5,880 |
$156.10 |
| 90713 |
|
181 |
136 |
$147.48 |
| 90656 |
|
572 |
354 |
$95.96 |
| 93000 |
|
664 |
472 |
$85.23 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,864 |
4,812 |
$85.08 |
| 94760 |
|
2,246 |
1,614 |
$74.76 |
| 59430 |
|
224 |
224 |
$60.48 |
| 86580 |
|
116 |
82 |
$40.00 |
| 96156 |
|
3,050 |
2,386 |
$16.83 |
| 99401 |
|
513 |
503 |
$16.83 |
| 81003 |
|
1,662 |
1,251 |
$10.77 |
| 90716 |
|
198 |
125 |
$9.00 |
| 90707 |
|
265 |
165 |
$9.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
218 |
217 |
$4.24 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
3,626 |
2,350 |
$0.00 |
| 3074F |
|
6,640 |
5,936 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
86 |
64 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,761 |
3,733 |
$0.00 |
| 3008F |
|
2,028 |
1,965 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,063 |
2,061 |
$0.00 |
| Z1034 |
|
10,360 |
7,013 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
3,766 |
3,751 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,685 |
1,684 |
$0.00 |
| 81001 |
|
1,434 |
1,417 |
$0.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
338 |
324 |
$0.00 |
| 3075F |
|
1,305 |
1,268 |
$0.00 |
| 90619 |
|
628 |
466 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,365 |
4,350 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,180 |
3,177 |
$0.00 |
| 86592 |
|
2,067 |
2,062 |
$0.00 |
| 82950 |
|
439 |
438 |
$0.00 |
| Z6410 |
|
1,280 |
1,228 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
181 |
118 |
$0.00 |
| 88142 |
|
336 |
335 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,375 |
2,372 |
$0.00 |
| 90677 |
|
115 |
115 |
$0.00 |
| 87070 |
|
29 |
29 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
916 |
902 |
$0.00 |
| 3052F |
|
74 |
74 |
$0.00 |
| 80055 |
|
674 |
673 |
$0.00 |
| 97802 |
|
191 |
187 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
16 |
16 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
347 |
346 |
$0.00 |
| Z6406 |
|
379 |
373 |
$0.00 |
| Z6204 |
|
926 |
922 |
$0.00 |
| 3351F |
|
174 |
102 |
$0.00 |
| 87081 |
|
502 |
499 |
$0.00 |
| 3079F |
|
2,489 |
2,376 |
$0.00 |
| 99460 |
|
615 |
606 |
$0.00 |
| 82105 |
|
716 |
699 |
$0.00 |
| Z1032 |
|
950 |
949 |
$0.00 |
| 3014F |
|
122 |
121 |
$0.00 |
| 3080F |
|
127 |
116 |
$0.00 |
| Z1038 |
|
326 |
326 |
$0.00 |
| 1030F |
|
12 |
12 |
$0.00 |
| 4037F |
|
103 |
70 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
276 |
276 |
$0.00 |
| 86803 |
|
209 |
209 |
$0.00 |
| 82043 |
|
239 |
238 |
$0.00 |
| 99462 |
|
200 |
159 |
$0.00 |
| 90688 |
|
175 |
133 |
$0.00 |
| 90480 |
|
52 |
40 |
$0.00 |
| 87340 |
|
92 |
91 |
$0.00 |
| 85027 |
|
125 |
124 |
$0.00 |
| 1125F |
|
27 |
27 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
43 |
43 |
$0.00 |
| 86762 |
|
38 |
38 |
$0.00 |
| Z6402 |
|
457 |
457 |
$0.00 |
| 3017F |
|
25 |
25 |
$0.00 |
| 86901 |
|
13 |
13 |
$0.00 |
| S9452 |
Nutrition classes, non-physician provider, per session |
13 |
13 |
$0.00 |
| 86850 |
|
12 |
12 |
$0.00 |
| 94010 |
|
35 |
19 |
$0.00 |
| 99406 |
|
22 |
13 |
$0.00 |
| 3049F |
|
12 |
12 |
$0.00 |
| 1126F |
|
18 |
18 |
$0.00 |
| 99173 |
|
22,147 |
16,033 |
$0.00 |
| 3046F |
|
968 |
936 |
$0.00 |
| 90461 |
|
3,856 |
3,854 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
40 |
40 |
$0.00 |
| 80061 |
Lipid panel |
2,972 |
2,971 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,785 |
3,755 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
241 |
237 |
$0.00 |
| 3078F |
|
6,711 |
6,058 |
$0.00 |
| 3077F |
|
1,347 |
1,282 |
$0.00 |
| 1159F |
|
2,349 |
2,289 |
$0.00 |
| 86787 |
|
66 |
66 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,295 |
9,262 |
$0.00 |
| Z6202 |
|
249 |
249 |
$0.00 |
| 99177 |
|
1,835 |
1,438 |
$0.00 |
| Z6200 |
|
455 |
455 |
$0.00 |
| Z6304 |
|
296 |
296 |
$0.00 |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
185 |
185 |
$0.00 |
| 80076 |
|
345 |
344 |
$0.00 |
| Z6300 |
|
455 |
455 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
294 |
293 |
$0.00 |
| 90681 |
|
682 |
646 |
$0.00 |
| 3015F |
|
194 |
190 |
$0.00 |
| Z6400 |
|
970 |
970 |
$0.00 |
| 84702 |
|
257 |
236 |
$0.00 |
| 0521F |
|
116 |
112 |
$0.00 |
| 80074 |
|
378 |
376 |
$0.00 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
599 |
575 |
$0.00 |
| 99080 |
|
43 |
43 |
$0.00 |
| 2028F |
|
626 |
624 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
40 |
30 |
$0.00 |
| 3051F |
|
135 |
133 |
$0.00 |
| 97803 |
|
178 |
172 |
$0.00 |
| 90750 |
|
119 |
94 |
$0.00 |
| 90621 |
|
43 |
29 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
45 |
43 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
136 |
98 |
$0.00 |
| 3725F |
|
314 |
309 |
$0.00 |
| 90648 |
|
38 |
28 |
$0.00 |
| 84439 |
|
406 |
406 |
$0.00 |
| 83721 |
|
24 |
24 |
$0.00 |
| H1000 |
Prenatal care, at-risk assessment |
33 |
33 |
$0.00 |
| 3050F |
|
30 |
30 |
$0.00 |
| 90736 |
|
21 |
14 |
$0.00 |
| 91320 |
|
38 |
28 |
$0.00 |
| A4614 |
Peak expiratory flow rate meter, hand held |
27 |
26 |
$0.00 |
| 1039F |
|
27 |
26 |
$0.00 |